methotrexate 59 05 2

Methotrexate (59-05-2) Methotrexate is a cytotoxic drug used for cancer treatment. To reduce its cytotoxicity, it can be administered in conjunction with calcium leucovorin. This medication is primarily indicated for the treatment of acute lymphocytic leukemia, breast cancer, malignant mole and choriocarcinoma, head and neck cancer, bone cancer, leukemia, spinal cord meningeal infiltration, lung cancer, reproductive system cancer, liver cancer, as well as refractory psoriasis